Condition
Metabolic Syndrome
Metabolic syndrome is a cluster of linked problems, including high blood pressure, high blood sugar, extra belly fat, high triglycerides and low HDL cholesterol, that reflects how the body handles sugar and fat. Berberine and omega-3 fatty acids have the strongest evidence among supplements, and large berberine trials found blood sugar improved. Vitamin D also improved blood sugar, but only in a few small studies, and the evidence for magnesium and chromium was limited.
Sources: PMID 40259331; PMID 31950134
- Supplements studied
- 40
- Graded outcomes
- 40
- Trials
- 44
- People studied
- 149,257
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 6 studies | 796 people | ||
Studies that measured blood glucose
| ||||||
| Blood Pressure | Improves (the measure goes down) | 3 studies | 218 people | |||
Studies that measured blood pressure
| ||||||
| Weight | Improves (the measure goes down) | 3 studies | 120 people | |||
Studies that measured weight
| ||||||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 44 people | |||
Studies that measured tnf-alpha
| ||||||
| Triglycerides | Improves (the measure goes down) | 2 studies | 688 people | |||
Studies that measured triglycerides | ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 44 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 746 people | |||
| Hip Circumference | Improves (the measure goes down) | 1 study | 120 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 75 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 378 people | ||||
| Epidermal Growth Factor (EGF) | Improves (the measure goes up) | 44 people | ||||
| HbA1c | Improves (the measure goes down) | 571 people | ||||
| Insulin | Changes; see studies | 340 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 404 people | ||||
| Interferon Gamma | Improves (the measure goes up) | 44 people | ||||
| Interleukin 1-alpha | Improves (the measure goes up) | 44 people | ||||
| Interleukin 1-beta | Improves (the measure goes down) | 44 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 44 people | ||||
| Interleukin 2 | Improves (the measure goes up) | 44 people | ||||
| Interleukin 4 | Improves (the measure goes up) | 44 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 44 people | ||||
| Interleukin 8 | Changes; see studies | 44 people | ||||
| Leptin | Improves (the measure goes up) | 76 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 746 people | ||||
| Monocyte Chemoattractant Protein-1 | Improves (the measure goes up) | 44 people | ||||
| Total cholesterol | Improves (the measure goes down) | 840 people | ||||
| Vascular Endothelial Growth Factor | Improves (the measure goes up) | 44 people | ||||
| Waist circumference | Improves (the measure goes down) | 120 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 2 studies | 748 people | ||
Studies that measured blood glucose | ||||||
| Total cholesterol | Changes; see studies | 4 studies | 488 people | |||
Studies that measured total cholesterol
| ||||||
| Low-density lipoprotein (LDL) | Changes; see studies | 2 studies | 568 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| C-Reactive Protein (CRP) | Changes; see studies | 1 study | 727 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 568 people | |||
Studies that measured high-density lipoprotein (hdl) | ||||||
| HbA1c | Changes; see studies | 389 people | ||||
| Interleukin 6 | Changes; see studies | 156 people | ||||
| Oxidative Stress Biomarkers | Changes; see studies | 591 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 364 people | ||||
| TNF-Alpha | Changes; see studies | 307 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 480 people | ||||
| Triglycerides | Changes; see studies | 568 people | ||||
Vitamin D
- Blood glucose: improves
- Insulin: changes; see studies
- Low-density lipoprotein (LDL): improves
Inositol
- Blood glucose: improves
- Weight: improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 147 people | ||
| Weight | Improves (the measure goes down) | 6 studies | 147 people | |||
Studies that measured weight
| ||||||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 130 people | |||
Studies that measured glycemic control
| ||||||
| Insulin | Changes; see studies | 1 study | 130 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 97 people | |||
| Blood Pressure | Improves (the measure goes down) | 164 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 17 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 97 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 34 people | ||||
| PCOS Symptoms | Improves (the measure goes down) | 50 people | ||||
| Plasmalogens | Improves (the measure goes up) | 34 people | ||||
| Total cholesterol | Improves (the measure goes down) | 97 people | ||||
Whey Protein
- Blood glucose
- Insulin: changes; see studies
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Mixed effect | 1 study | 850 people | ||||
Studies that measured blood glucose | ||||||
| Insulin | Changes; see studies | 7 studies | 768 people | |||
Studies that measured insulin
| ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 2 studies | 939 people | |||
Studies that measured high-density lipoprotein (hdl)
| ||||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 1,000 people | |||
Studies that measured blood pressure | ||||||
| HbA1c | Improves (the measure goes down) | 246 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 807 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 827 people | ||||
| Total cholesterol | Improves (the measure goes down) | 901 people | ||||
| Total-/HDL-cholesterol ratio | Changes; see studies | 161 people | ||||
| Triglycerides | Improves (the measure goes down) | 1,018 people | ||||
| Waist circumference | Improves (the measure goes down) | 2,344 people | ||||
Curcumin
- Adiponectin: improves
- Blood glucose: improves
- Triglycerides: improves
Dihydroberberine
- Triglycerides: improves
- LDL Cholesterol: improves
- Total Cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Triglycerides Moderate Decrease - 0.50 mmol/L reduction (meta-analysis) | Improves (the measure goes down) | Moderate effect | 800 people | |||
| LDL Cholesterol Moderate Decrease - 0.65 mmol/L reduction | Improves (the measure goes down) | Moderate effect | 700 people | |||
| Total Cholesterol Moderate Decrease - 0.61 mmol/L reduction | Improves (the measure goes down) | Moderate effect | 700 people | |||
| Waist Circumference 3.27 cm reduction (meta-analysis) | Improves (the measure goes down) | Moderate effect | 400 people |
Berberine
- Blood glucose: improves
- HbA1c: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Large Improvement | Improves (the measure goes down) | Large effect | 2,737 people | |||
| HbA1c | Improves (the measure goes down) | 5 studies | 1,156 people | |||
Studies that measured hba1c
| ||||||
| Total cholesterol | Improves (the measure goes down) | 3 studies | 2,804 people | |||
Studies that measured total cholesterol
| ||||||
| Glycemic Control | Improves (the measure goes up) | 2 studies | 24 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 2 studies | 2,784 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 3,004 people | |||
| Blood Pressure | Improves (the measure goes down) | 1,426 people | ||||
| Insulin | Changes; see studies | 1,138 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 1,119 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 2,824 people | ||||
Resveratrol
- Adiponectin: improves
- Blood glucose: improves
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 285 people | |||
| Blood glucose | Improves (the measure goes down) | 7 studies | 329 people | |||
Studies that measured blood glucose
| ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 869 people | |||
Studies that measured c-reactive protein (crp)
| ||||||
| Weight | Improves (the measure goes down) | 3 studies | 582 people | |||
Studies that measured weight
| ||||||
| Kidney Function | Improves (the measure goes up) | 2 studies | 135 people | |||
Studies that measured kidney function | ||||||
| Liver Enzymes | Changes; see studies | 2 studies | 2,474 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 863 people | |||
| Vascular Function | Improves (the measure goes up) | 2 studies | 268 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 1,648 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 541 people | |||
| Blood Urea Nitrogen (BUN) | Improves (the measure goes up) | 894 people | ||||
| Body Fat | Improves (the measure goes down) | 516 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1,418 people | ||||
| HbA1c | Improves (the measure goes down) | 271 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 793 people | ||||
| Insulin | Changes; see studies | 172 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 191 people | ||||
| Intercellular Adhesion Molecule 1 | Changes; see studies | 1,034 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 631 people | ||||
| Leptin | Improves (the measure goes up) | 271 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 791 people | ||||
| Plasminogen Inhibitor-1 | Improves (the measure goes up) | 1,034 people | ||||
| Serum Albumin | Improves (the measure goes up) | 516 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 118 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 483 people | ||||
| Uric Acid | Improves (the measure goes down) | 353 people | ||||
| Waist circumference | Improves (the measure goes down) | 335 people | ||||
Folic Acid (Vitamin B9)
- C-Reactive Protein (CRP): improves
- TNF-Alpha: improves
- Interleukin 6: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 321 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 127 people | |||
Studies that measured tnf-alpha
| ||||||
| Interleukin 6 | Improves (the measure goes down) | 191 people | ||||
Magnesium
- Blood glucose: improves
- Blood Pressure: improves
- Serum Magnesium: improves
Chromium
- Blood glucose: improves
- Weight: improves
- Glycemic Control: improves
Panax Ginseng (Korean Ginseng)
- Blood glucose: improves
- Insulin: changes; see studies
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 48 people | ||
| Insulin | Changes; see studies | 3 studies | 48 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 48 people | |||
| Blood Pressure | Improves (the measure goes down) | 48 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 48 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 48 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 48 people | ||||
| Total cholesterol | Improves (the measure goes down) | 48 people | ||||
| Triglycerides | Improves (the measure goes down) | 48 people |
Zinc
- Anti-Oxidant Enzyme Profile: improves
- Apolipoprotein A: improves
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 40 people | ||
| Apolipoprotein A | Improves (the measure goes up) | 1 study | 60 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 60 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 120 people | |||
| Insulin | Changes; see studies | 1 study | 120 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 100 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 60 people | ||||
| Blood glucose | Improves (the measure goes down) | 120 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 60 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 60 people | ||||
| Leptin | Improves (the measure goes up) | 60 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 120 people | ||||
| Total cholesterol | Improves (the measure goes down) | 60 people | ||||
| Triglycerides | Improves (the measure goes down) | 60 people | ||||
| Weight | Improves (the measure goes down) | 120 people |
Milk Protein
- Blood glucose
- Blood Pressure: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Mixed effect | 1 study | 4,229 people | ||||
| Blood Pressure | Improves (the measure goes down) | 822 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 76 people | ||||
| Insulin | Changes; see studies | 44 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 76 people | ||||
| Total cholesterol | Improves (the measure goes down) | 76 people | ||||
| Triglycerides | Improves (the measure goes down) | 76 people |
Grape Seed Extract
- Blood Pressure: improves
- High-density lipoprotein (HDL): improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 27 people | ||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 27 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 27 people | |||
| LDL Oxidation | Improves (the measure goes down) | 27 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 27 people | ||||
| Total cholesterol | Improves (the measure goes down) | 27 people |
Melatonin
- Anti-Oxidant Enzyme Profile: improves
- Blood Pressure: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 30 people | |||
| Blood glucose | Improves (the measure goes down) | 30 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 30 people | ||||
| Fibrinogen | Improves (the measure goes up) | 30 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 30 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 30 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 30 people | ||||
| Total cholesterol | Improves (the measure goes down) | 30 people | ||||
| Triglycerides | Improves (the measure goes down) | 30 people |
Green Tea Extract
- Oxidative Stress Biomarkers: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Oxidative Stress Biomarkers Small Decrease | Improves (the measure goes down) | Small effect | 35 people | |||
| Weight | Improves (the measure goes down) | 6 studies | 35 people |
Spirulina
- Adiponectin: improves
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 52 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 5 studies | 510 people | |||
| Total cholesterol | Improves (the measure goes down) | 5 studies | 510 people | |||
| Body Fat | Improves (the measure goes down) | 2 studies | 52 people | |||
| HbA1c | Improves (the measure goes down) | 2 studies | 510 people | |||
| Appetite | Changes; see studies | 1 study | 52 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 510 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 510 people | |||
| Weight | Improves (the measure goes down) | 1 study | 52 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 52 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 510 people | ||||
| Hip Circumference | Improves (the measure goes down) | 52 people | ||||
| Insulin | Changes; see studies | 510 people | ||||
| Muscle Mass | Improves (the measure goes up) | 52 people | ||||
| vLDL-C | Improves (the measure goes down) | 510 people | ||||
| Waist circumference | Improves (the measure goes down) | 52 people | ||||
| Waist-Hip Ratio | Improves (the measure goes up) | 52 people |
Betaine
- Apolipoprotein A: improves
- Homocysteine: changes; see studies
- Serum Cobalamin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A Small Increase | Improves (the measure goes up) | Small effect | 27 people | |||
| Homocysteine | Changes; see studies | 4 studies | 61 people | |||
| Serum Cobalamin | Improves (the measure goes up) | 2 studies | 34 people | |||
| Fibrinogen | Improves (the measure goes up) | 1 study | 27 people | |||
| Total cholesterol | Changes; see studies | 1 study | 27 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 27 people | ||||
| LDL Oxidation | Changes; see studies | 27 people | ||||
| Liver Enzymes | Changes; see studies | 27 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 27 people | ||||
| Plasminogen Inhibitor-1 | Improves (the measure goes up) | 27 people | ||||
| Serum Folate | Improves (the measure goes up) | 34 people |
L-Carnitine
- Adiponectin: improves
- High-density lipoprotein (HDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 32 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 12 studies | 321 people | |||
| Total cholesterol | Improves (the measure goes down) | 6 studies | 207 people | |||
| Blood glucose | Improves (the measure goes down) | 5 studies | 303 people | |||
| Triglycerides | Improves (the measure goes down) | 4 studies | 375 people | |||
| Insulin | Changes; see studies | 3 studies | 30 people | |||
| Free Fatty Acids | Improves (the measure goes up) | 2 studies | 30 people | |||
| Liver Enzymes | Changes; see studies | 2 studies | 30 people | |||
| Atherosclerotic Signs | Improves (the measure goes up) | 1 study | 177 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 66 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 30 people | |||
| Weight | Improves (the measure goes down) | 1 study | 30 people | |||
| Apolipoprotein A | Improves (the measure goes up) | 30 people | ||||
| Apolipoprotein B | Improves (the measure goes down) | 30 people | ||||
| Appetite | Changes; see studies | 30 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 30 people | ||||
| Glycemic Control | Improves (the measure goes up) | 62 people | ||||
| Hip Circumference | Improves (the measure goes down) | 30 people | ||||
| Lipoprotein(a) | Improves (the measure goes up) | 30 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 207 people | ||||
| Uric Acid | Improves (the measure goes down) | 30 people | ||||
| Waist circumference | Improves (the measure goes down) | 115 people |
Olive Leaf Extract
- Blood glucose: improves
- Blood Pressure: improves
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 45 people | |||
| Blood Pressure | Improves (the measure goes down) | 2 studies | 45 people | |||
| Liver Enzymes | Changes; see studies | 1 study | 45 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 45 people | |||
| Glycemic Control | Improves (the measure goes up) | 45 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 45 people | ||||
| IGF Binding Protein | Improves (the measure goes up) | 45 people | ||||
| IGF-1 | Improves (the measure goes up) | 45 people | ||||
| Inflammation | Improves (the measure goes down) | 45 people | ||||
| Insulin | Changes; see studies | 45 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 45 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 45 people | ||||
| Triglycerides | Improves (the measure goes down) | 45 people |
Akkermansia muciniphila
- Insulinemia: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insulinemia -34% reduction in plasma insulin levels | Improves (the measure goes down) | Moderate effect | 32 people |
Cocoa Extract
- High-density lipoprotein (HDL)
- Triglycerides: improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect | NoneNo effect | 13 studies | 23 people | |||
| Triglycerides | Improves (the measure goes down) | 3 studies | 23 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 23 people | |||
| LDL Oxidation | Improves (the measure goes down) | 23 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 23 people | ||||
| Total cholesterol | Improves (the measure goes down) | 23 people | ||||
| vLDL-C | Improves (the measure goes down) | 23 people |
Conjugated Linoleic Acid
- Body Fat
- High-density lipoprotein (HDL): improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat No effect | NoneNo effect | 7 studies | 60 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 6 studies | 60 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 6 studies | 60 people | |||
| Weight | Improves (the measure goes down) | 6 studies | 60 people | |||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 60 people | |||
| Triglycerides | Improves (the measure goes down) | 60 people |
Alpha-Lipoic Acid
- Blood Pressure
- Inflammation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure No effect | NoneNo effect | 3 studies | 58 people | |||
| Inflammation | Changes; see studies | 2 studies | 58 people |
Roselle
- Blood glucose
- Blood Pressure: improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 1 study | 94 people | |||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 94 people | |||
| Triglycerides | Improves (the measure goes down) | 3 studies | 94 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 94 people | ||||
| Kidney Function | Improves (the measure goes up) | 94 people | ||||
| Liver Enzymes | Changes; see studies | 94 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 94 people | ||||
| Total cholesterol | Improves (the measure goes down) | 94 people | ||||
| Urea | Improves (the measure goes up) | 94 people |
Astaxanthin
- Blood glucose
- Total cholesterol: changes; see studies
- Triglycerides: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 1 study | 175 people | |||
| Total cholesterol | Changes; see studies | 2 studies | 450 people | |||
| Triglycerides | Changes; see studies | 2 studies | 445 people | |||
| Body Mass Index (BMI) | Changes; see studies | 1 study | 162 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 485 people | |||
| Blood Pressure | Changes; see studies | 297 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 485 people |
Hesperidin
- Apolipoprotein A
- Low-density lipoprotein (LDL): improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 24 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 24 people | |||
| Blood glucose | Improves (the measure goes down) | 2 studies | 24 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 24 people | |||
| Blood Flow | Improves (the measure goes up) | 1 study | 24 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 24 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 24 people | ||||
| Blood Pressure | Improves (the measure goes down) | 24 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 24 people | ||||
| Fibrinogen | Improves (the measure goes up) | 24 people | ||||
| Glycemic Control | Improves (the measure goes up) | 24 people | ||||
| HbA1c | Improves (the measure goes down) | 24 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 24 people | ||||
| Homocysteine | Improves (the measure goes down) | 24 people | ||||
| Insulin | Changes; see studies | 24 people | ||||
| Triglycerides | Improves (the measure goes down) | 24 people | ||||
| Weight | Improves (the measure goes down) | 24 people |
Flaxseed
- Adiponectin
- C-Reactive Protein (CRP): improves
- Leptin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 284 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 4 studies | 697 people | |||
| Leptin | Improves (the measure goes up) | 2 studies | 284 people | |||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 1 study | 697 people | |||
| Glutathione (GSH) | Improves (the measure goes up) | 697 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 697 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 697 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 697 people |
Probiotics
- Body Mass Index (BMI)
- Weight: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Mass Index (BMI) No effect | NoneNo effect | 244 people | ||||
| Weight | Improves (the measure goes down) | 1 study | 422 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 412 people | ||||
| Visceral Fat | Improves (the measure goes down) | 231 people | ||||
| Waist circumference | Improves (the measure goes down) | 297 people |
Casein
- Blood glucose
- Triglycerides: improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 80 people | ||||
| Triglycerides | Improves (the measure goes down) | 1 study | 121 people | |||
| Blood Pressure | Improves (the measure goes down) | 183 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 121 people | ||||
| Insulin | Changes; see studies | 30 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 121 people | ||||
| Total cholesterol | Improves (the measure goes down) | 121 people |
Roselle
- Blood glucose
- Blood Pressure: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 94 people | ||||
| Blood Pressure | Improves (the measure goes down) | 94 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 94 people | ||||
| Kidney Function | Improves (the measure goes up) | 94 people | ||||
| Liver Enzymes | Changes; see studies | 94 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 94 people | ||||
| Total cholesterol | Improves (the measure goes down) | 94 people | ||||
| Triglycerides | Improves (the measure goes down) | 94 people | ||||
| Urea | Improves (the measure goes up) | 94 people |
Dill
- Blood glucose
- Total cholesterol: improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 200 people | ||||
| Total cholesterol | Improves (the measure goes down) | 3 studies | 270 people | |||
| Blood Pressure | Improves (the measure goes down) | 20 people | ||||
| Glycemic Control | Improves (the measure goes up) | 100 people | ||||
| Heart Rate | Improves (the measure goes down) | 20 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 270 people | ||||
| Insulin | Changes; see studies | 100 people | ||||
| Kidney Function | Improves (the measure goes up) | 20 people | ||||
| Liver Enzymes | Changes; see studies | 20 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 270 people | ||||
| Triglycerides | Improves (the measure goes down) | 270 people | ||||
| Weight | Improves (the measure goes down) | 20 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 20 people |
Soy Protein
- Blood glucose
- Blood Pressure: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 521 people | ||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 1,203 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1,008 people | ||||
| Insulin | Changes; see studies | 4,229 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 982 people | ||||
| Total cholesterol | Improves (the measure goes down) | 998 people | ||||
| Triglycerides | Improves (the measure goes down) | 1,087 people |
Bitter Melon
- Traditional Use for Metabolic Syndrome
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Traditional Use for Metabolic Syndrome Systematic review: Insufficient high-quality evidence to support efficacy for metabolic syndrome parameters. Traditional use widespread but clinical validation lacking. More rigorous trials needed. | Small effect |
Resistant Starch
- C-Reactive Protein (CRP)
- TNF-Alpha: improves
- Interleukin 6: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 467 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 1 study | 467 people | |||
| Interleukin 6 | Improves (the measure goes down) | 467 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 467 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 467 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 467 people |
Coenzyme Q10
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure | Improves (the measure goes down) | 4 studies | 30 people |
Fish Oil
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure | Improves (the measure goes down) | 2 studies | 65 people |
Niacin (Vitamin B3)
- Low-density lipoprotein (LDL): improves
- High-density lipoprotein (HDL): improves
- Glycemic Control: worsens
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 2 studies | 20 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 20 people | |||
| Glycemic Control Small Detriment | Worsens (the measure goes down) | Small effect | 20 people | |||
| Hepatic Glucose Production | Changes; see studies | 20 people | ||||
| Triglycerides | Improves (the measure goes down) | 20 people | ||||
| vLDL-C | Improves (the measure goes down) | 20 people |
Key findings
- Blood glucoseImproves (the measure goes down)
- AdiponectinImproves (the measure goes up)
- TriglyceridesImproves (the measure goes down)
The Metabolic Syndrome protocol
2 primary supplements · 4 supporting supplements
- Berberine500 mg 2–3× daily with meals
- Omega-3 Fatty Acids2–4 g EPA/DHA daily
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Metabolic Syndrome. Each opens third-party tested products for that supplement.
- Grade B
- Grade B
- Grade B
- Grade B
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
11 studies from PubMed
- Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study
- Comparison of the Mediterranean Diet and Other Therapeutic Strategies in Metabolic Syndrome: A Systematic Review and Meta-Analysis.
- The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults.
- Lack of Efficacy of Pomegranate Supplementation on Insulin Resistance and Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis
- Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study
- Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study
- Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss
- Very low carbohydrate (ketogenic) diets in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
- The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome
- Association of Major Food Sources of Fructose-Containing Sugars With Incident Metabolic Syndrome: A Systematic Review and Meta-analysis.